Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-009150
Filing Date
2025-11-20
Accepted
2025-11-20 16:21:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3378
  Complete submission text file 0001950047-25-009150.txt   4898
Mailing Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402
Business Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 (650) 561-8600
Sagimet Biosciences Inc. (Subject) CIK: 0001400118 (see all company filings)

EIN.: 205991472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-41742 | Film No.: 251503327
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address SAGIMET BIOSCIENCES INC. 155 BOVET RD., STE. 303 SAN MATEO CA 94402
Business Address
Kemble George (Reporting) CIK: 0001858176 (see all company filings)

Type: 144